Publicado em 25/07/2025 às 20:35
This Nasdaq-Listed Drug Company Is Set to Buy $700 Million in BNB
This Nasdaq-Listed Drug Company Is Set to Buy $700 Million in BNB Windtree Therapeutics plans to buy up to $700 million worth of BNB for its balance sheet, partnering with Kraken for custody. The comp... [3278 symbols]
PUBLICIDADE